NovaBridge Biosciences (NBP) Construction in Progress (2021 - 2022)
NovaBridge Biosciences (NBP) reported Construction in Progress of $874276.2 for Q4 2022, down 73.51% year-over-year from $3.3 million in Q4 2021, and down 73.51% quarter-over-quarter from $3.3 million in Q4 2021.
NovaBridge Biosciences (NBP) Construction in Progress (2021 - 2022) Analysis & Trends
NovaBridge Biosciences (NBP) has 2 years of Construction in Progress data on file, last reported at $874276.2 in Q4 2022.
- Construction in Progress for Q4 2022 came in at $874276.2, down 73.51% year-over-year; the trailing twelve-month figure through Dec 2022 was $874276.2 (down 73.51% YoY), and the FY2022 annual result was $901000.0, down 72.7% from the prior year.
- Construction in Progress declined to $874276.2 in Q4 2022 per NBP's latest filing, from $3.3 million in the prior quarter.
- Over five years, Construction in Progress peaked at $3.3 million in Q4 2021 and troughed at $874276.2 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 874,276.16 |
| Dec 31, 2021 | 3.30 Mn |